BCLAF1 and acute myeloid leukemia: The highly expressed BCLAF1 was found to be correlated with the decreased overall survival of AML patients in the TCGA cohort (Figure 5B), indicating that the prognosis for patients with highly expressed BCLAF1 is poor.